Retired pharmacist ALS symptoms improved with chylobinoid

I’m a recently retired pharmacist of 48 years, the last 35 of which have been spent in a hospital/clinical setting. I’ve specialized in inpatient pain control for the last 20 years. I was diagnosed with bulbar-onset ALS (amyolateral sclerosis) roughly one year ago. I’ve been taking and continue to take FDA-approved ALS medications and have now exhausted all that traditional medicine can presently provide.

There are very few agents that are classified as true neuroprotectives and CBD is one of them. A few months ago, I obtained a ‘green card’ and tried CBD oil bought in a registered cannabis dispensary. I subsequently noticed a slight improvement in my speech and swallowing since trying this, but nothing remarkable.

My recent use of Synthonics’ “chylobinoid” drug (metallo-CBDa) has been a different story; when I take it, I’ve noticed an increased improvement in my speech, likely due to its increased bioavailability, or possibly its greater affinity and effect on certain receptors.  The ultimate point here is not the exact mechanism of chylobinoid’s increased efficacy, but the fact that it simply seems to work better than ‘regular’ CBD oil and I greatly prefer it to the CBD products I’ve tried. I would recommend it wholeheartedly to other ALS patients in hopes that their experience will be as positive as mine.